Tailoring Endoscopic and Surgical Treatments for Gastroesophageal Reflux Disease

Charles T. Bakhos, Abbas E. Abbas, Roman V. Petrov

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations


The incidence of gastroesophageal reflux disease (GERD) remains on the rise. Pathophysiology of GERD is multifactorial, revolving around an incompetent esophagogastric junction as an antireflux barrier, with other comorbid conditions contributing to the disease. Proton pump inhibitors remain the most common treatment of GERD. Endoscopic therapy has gained popularity as a less invasive option. The presence of esophageal dysmotility complicates the choice of surgical fundoplication. Most literature demonstrates that fundoplication is safe in the setting of ineffective or weak peristalsis and that postoperative dysphagia cannot be predicted by preoperative manometry parameters. More data are needed on the merits of endoluminal approaches to GERD.

Original languageEnglish (US)
Pages (from-to)467-480
Number of pages14
JournalGastroenterology Clinics of North America
Issue number3
StatePublished - Sep 2020
Externally publishedYes


  • Dysphagia
  • Esophagus
  • Fundoplication
  • Incisionless
  • Manometry
  • Reflux
  • Transoral

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'Tailoring Endoscopic and Surgical Treatments for Gastroesophageal Reflux Disease'. Together they form a unique fingerprint.

Cite this